Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Posts tagged Nath Bio-Genes

Fav Stock Of Mudar Patherya, Satpal Khattar Is At ‘Inflection Point’ & ‘Strong Buy’: Expert



Nath-Bio-Genes

Billionaire Satpal Khattar and Mudar Patherya are jointly bullish about a stock said to be “at cusp of unprecedented opportunities”. Now, SMIFS has opined that the stock is at ‘inflection point’ and recommended a ‘strong buy’ for hefty gains of 55%

Easy To Build Portfolio Of Multibaggers Now Says Kenneth Andrade & Discusses His Latest Stock Picks



kenneth andrade portfolio

Kenneth Andrade of Old Bridge Capital has sent the wake up call that we have to take advantage of the crash in stock prices to load up on high-quality stocks at cheap valuations. He has also explained the investment rationale of his latest stock picks

Mohnish Pabrai Dumps Foreign Stocks, Buys Two High-Quality Multibagger Indian Stocks



Mohnish Pabrai Repco Multibagger

Mohnish Pabrai’s appetite for Indian stocks has been whetted by the magnificent 10-bagger gains that he effortlessly snared. He is now dumping his portfolio of USA stocks and buying high-quality Indian stocks. No doubt, the strategy is very sensible and should be emulated by all deep-pocketed foreign investors

Fav Stock Of Billionaire Satpal Khattar Is “At Cusp Of Big Opportunities”: Mudar Patherya



Satpal Khattar Latest Portfolio

Billionaire Satpal Khattar has bought a big chunk of a high-quality micro-cap stock. Mudar Patherya has analyzed the stock and recommended a buy on the premise that it is at the “cusp of big opportunities” and will deliver multibagger gains in the near future

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 509 other subscribers

RSS Stocks Talk Forum

  • Raymond Lifestyle has multiple growth drivers. Target Price ₹3000 (+49%)
    Raymond Lifestyle has multiple growth drivers. It boasts legacy of established brands such as Park Avenue. However brands remain under-penetrated due to sluggish execution in past. Renewed focus on growth could lead to valuation re-rating. TP ₹3000 (+49%) Download research report... Raymond Lifestyle has multiple growth drivers. Target Price ₹3000 (+49%)
  • Sunil Singhania's Abakkus has bought 10.69L shares of Aarti Pharma at ₹575 for ₹61.5 Cr
    Sunil Singhania's Abakkus has bought 10.69L shares of Aarti Pharma at ₹575 for ₹61.5 Cr. M-Cap is ₹5800 Cr. Promoters hold 46%. Co operates in 3 areas i.e. Xanthine derivatives, API & CDMO/CMO. It is largest Indian manufacturer of Xanthines & has Global market share of 15-20% ... Sunil Singhania's Abakkus has bought 10.69L shares […]
  • PNB Housing is undergoing a transformation to morph into a franchise that will be stronger
    PNB Housing is undergoing a transformation to morph into a franchise that will be stronger, more resilient & with high predictability in earnings trajectory. Risk-reward profile is favorable for a long-term investor. Buy for TP of ₹1160 (38% upside) Download research... PNB Housing is undergoing a transformation to morph into a franchise that will be […]
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!